Veterinary Medicines

AVINEW

Authorised
  • Newcastle disease virus, strain VG/GA, Live
Download as PDF

Product identification

Medicine name:
AVINEW
Avinew
Active substance:
  • Newcastle disease virus, strain VG/GA, Live
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Chicken (broiler)
Route of administration:
  • Ocular use
  • Oral use
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain VG/GA, Live
    5.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Ocular use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Oral use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
  • Oculonasal use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • Box of one 2,000-dose bottle
  • Box of ten 1,000-dose bottles
  • Box of ten 2,000-dose bottles
  • Box of one 1,000-dose bottle

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • PEI
Authorisation number:
  • PEI.V.02053.01.1
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0123/001
Concerned member states:
  • Belgium
  • Germany
  • Greece
  • Luxembourg
  • Netherlands
  • Portugal
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 10/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."